Healthcare
AEYE Health AI diabetic eye-screening system wins Prix Galien award
AEYE Health’s FDA-cleared autonomous diabetic eye-screening technology won the 2026 Prix Galien USA award for Best Digital Health Solution.
AEYE Health announced that its autonomous AI diagnostic system, AEYE-DS, won the 2026 Prix Galien USA award for Best Digital Health Solution. The company describes AEYE-DS as an FDA-cleared portable system for diabetic eye examinations that can operate without physician interpretation at the point of care. The technology is designed to make diabetic retinopathy screening more accessible in locations that may not have specialist ophthalmology staff. The award recognizes the use of autonomous AI in a preventive-care workflow rather than only in specialist hospitals. Wider deployment could help healthcare providers identify eye disease earlier and extend screening capacity. The announcement also highlights the growing role of portable AI diagnostics in community and primary-care settings, where access to specialist review can be limited. Clinical implementation still depends on appropriate referral pathways for patients whose screenings indicate possible disease.
Original source: PR Newswire